July 3, 2024 — Over the past decade, 342 cardiology clinics have been acquired by private equity firms, with over 94% of ...
July 3, 2024 — Jon Kobashigawa, MD, director of the Heart Transplant Program in the Department of Cardiology in the ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
July 2, 2024 — Biotronik announced the availability of an expanded Maximum Allowed Diameters (MAD) range for the Orsiro ...
July 2, 2024 — The U.S. Food and Drug Administration (FDA) announced that Abbott has issued a correction for its ...

From FDA approvals to new clinical trials, here is a look at DAIC's top-read content during the month of June: 1 ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
July 1, 2024 — CVRx, Inc., a commercial-stage medical device company, announced three additions to its senior leadership ...
June 28, 2024 — AstraZeneca has set out a new ambition for Healthy Heart Africa, its flagship health equity initiative ...
June 28, 2024 — After a year of dedicated service and outstanding leadership, Jodie L. Hurwitz, MD, FHRS, has now ended ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
June 27, 2024 — The human body has sophisticated defenses against the deposition of calcium minerals that stiffen heart ...
June 27, 2024 — The sheer scale of undiagnosed heart valve disease in our aging population has been revealed for the ...
June 27, 2024 — Cardiovascular disease is the leading cause of death for women, and gaps in care and access persist ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...

June 27, 2024 — The countdown has begun for the Society of Cardiovascular Computed Tomography (SCCT) 19th Annual ...
June 26, 2024 — Anumana, a leading AI-driven health technology company and portfolio company of nference, and InfoBionic ...
June 26, 2024 — Semaglutide, a medication initially developed for type 2 diabetes and obesity, significantly improves ...